Clinical Trial Update: BCG With or Without Mitomycin in Treating Patients With Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Bacillus Calmette-Guérin with or without Mitomycin C for bladder cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• BCG (Bacillus Calmette-Guérin)
• Mitomycin (Mitomycin)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Bladder Cancer | Phase 2 | Status: COMPLETED